astilbin has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, YF; Fan, XY; Lou, LJ; Wang, SW; Weng, YY; Xu, Y; Zhang, F; Zheng, XY | 1 |
| Chen, L; Lan, Z; Li, F; Li, P; Yang, Z; Zhang, C; Zhang, X; Zhou, Y | 1 |
2 other study(ies) available for astilbin and Kidney Diseases
| Article | Year |
|---|---|
Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Flavonols; HEK293 Cells; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Oxidative Stress | 2018 |
Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
Topics: Animals; Blood Urea Nitrogen; Connective Tissue Growth Factor; Creatinine; Dinoprostone; Disease Models, Animal; Drugs, Chinese Herbal; Flavonols; Fructose; Hyperuricemia; Interleukin-1; Kidney; Kidney Diseases; Male; Phytotherapy; Rats; Rats, Sprague-Dawley; Rhizome; Smilax; Transforming Growth Factor beta1; Uric Acid; Xanthine Oxidase | 2011 |